OverT Bio Secures $16M to Optimize Cell Therapy for Solid Tumors - HIT Consultant

Retrieved on: 2024-05-06 22:17:34

Tags for this article:

Click the tags to see associated articles and topics

OverT Bio Secures $16M to Optimize Cell Therapy for Solid Tumors - HIT Consultant. View article details on hiswai:

Excerpt

Synthetic Biology Techniques: OverT Bio utilizes synthetic biology to engineer next-generation cell therapies with superior efficacy. OverT Bio's ...

Article found on: hitconsultant.net